{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:25:34Z","timestamp":1793651134876,"version":"4.5.1"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,12,14]]},"DOI":"10.1001\/jama.2021.20956","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T11:44:28Z","timestamp":1639482268000},"page":"2277","source":"Crossref","is-referenced-by-count":243,"title":["Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke"],"prefix":"10.1001","volume":"326","author":[{"given":"David M.","family":"Kent","sequence":"first","affiliation":[{"name":"Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center\/Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Saver","sequence":"additional","affiliation":[{"name":"Comprehensive Stroke Center and Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Kasner","sequence":"additional","affiliation":[{"name":"Comprehensive Stroke Center, Department of Neurology, University of Pennsylvania Medical Center, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Nelson","sequence":"additional","affiliation":[{"name":"Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center\/Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Colorado Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Chatellier","sequence":"additional","affiliation":[{"name":"Centre d\u2019Investigations Cliniques, Unit\u00e9 de Recherche Clinique, H\u00f4pital Europ\u00e9en Georges\u2013Pompidou, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Derumeaux","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Physiologie, H\u00f4pital Henri Mondo, Assistance Publique\u2013H\u00f4pitaux de Paris, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Furlan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard C.","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[{"name":"Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michael\u2019s Hospital, University of Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Koethe","sequence":"additional","affiliation":[{"name":"Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center\/Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Hyung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Lefebvre","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich P.","family":"Mattle","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bern University Hospital, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Meier","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bern University Hospital, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Reisman","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Washington Medical Center, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Smalling","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, UTHealth\/McGovern Medical School, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Soendergaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Copenhagen Hospital Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Kwan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Mas","sequence":"additional","affiliation":[{"name":"GHU Paris Psychiatrie et Neurosciences, H\u00f4pital Sainte-Anne, D\u00e9partement of Neurology, Institut de Psychiatrie et Neurosciences de Paris, Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Thaler","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tufts Medical Center\/Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"joi210128r1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/STROKEAHA.117.018153","article-title":"Patent foramen ovale closure versus medical therapy for cryptogenic ischemic stroke: a topical review.","volume":"49","author":"Saver","year":"2018","journal-title":"Stroke"},{"issue":"7","key":"joi210128r2","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association.","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"38","key":"joi210128r3","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1093\/eurheartj\/ehy649","article-title":"European position paper on the management of patients with patent foramen ovale: general approach and left circulation thromboembolism.","volume":"40","author":"Pristipino","year":"2019","journal-title":"Eur Heart J"},{"issue":"20","key":"joi210128r4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1212\/WNL.0000000000009443","article-title":"Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the guideline subcommittee of the American Academy of Neurology.","volume":"94","author":"Mess\u00e9","year":"2020","journal-title":"Neurology"},{"issue":"12","key":"joi210128r5","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.","volume":"368","author":"Carroll","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"joi210128r6","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke.","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"joi210128r7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke.","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"joi210128r8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism.","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"joi210128r9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale.","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"joi210128r10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs antiplatelets after stroke.","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"joi210128r11","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO Trial.","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"joi210128r12","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/eurheartj\/ehy121","article-title":"Patent foramen ovale closure vs medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials.","volume":"39","author":"Ahmad","year":"2018","journal-title":"Eur Heart J"},{"key":"joi210128r13","doi-asserted-by":"crossref","first-page":"k4245","DOI":"10.1136\/bmj.k4245","article-title":"Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.","volume":"363","author":"Kent","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"joi210128r14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7326\/M18-3667","article-title":"The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement.","volume":"172","author":"Kent","year":"2020","journal-title":"Ann Intern Med"},{"issue":"6","key":"joi210128r15","first-page":"2184","article-title":"Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence.","volume":"45","author":"Dahabreh","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"16","key":"joi210128r16","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD statement.","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"issue":"7","key":"joi210128r17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke.","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"issue":"7","key":"joi210128r18","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/jamaneurol.2020.0458","article-title":"Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke.","volume":"77","author":"Elgendy","year":"2020","journal-title":"JAMA Neurol"},{"issue":"10","key":"joi210128r19","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1161\/STROKEAHA.120.029350","article-title":"Risk of Paradoxical Embolism (RoPE): estimated attributable fraction correlates with the benefit of patent foramen ovale closure: an analysis of 3 trials.","volume":"51","author":"Kent","year":"2020","journal-title":"Stroke"},{"issue":"1","key":"joi210128r20","doi-asserted-by":"publisher","first-page":"NP7","DOI":"10.1177\/1747493015607505","article-title":"The utility of the RoPE score in cryptogenic stroke patients =50 years in predicting a stroke-related patent foramen ovale.","volume":"11","author":"Prefasi","year":"2016","journal-title":"Int J Stroke"},{"issue":"5","key":"joi210128r21","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/STROKEAHA.120.032453","article-title":"Embolic stroke of undetermined source and patent foramen ovale: risk of paradoxical embolism score validation and atrial fibrillation prediction.","volume":"52","author":"Strambo","year":"2021","journal-title":"Stroke"},{"issue":"24","key":"joi210128r22","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.","volume":"345","author":"Mas","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"joi210128r23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1046\/j.1468-1331.2003.00561.x","article-title":"Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale.","volume":"10","author":"Anzola","year":"2003","journal-title":"Eur J Neurol"},{"issue":"3","key":"joi210128r24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/sim.3782","article-title":"Improving propensity score weighting using machine learning.","volume":"29","author":"Lee","year":"2010","journal-title":"Stat Med"},{"issue":"12","key":"joi210128r25","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1056\/NEJMe1301680","article-title":"Still no closure on the question of PFO closure.","volume":"368","author":"Mess\u00e9","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"joi210128r26","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/STROKEAHA.111.634352","article-title":"Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project.","volume":"43","author":"Saver","year":"2012","journal-title":"Stroke"},{"issue":"9","key":"joi210128r27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 Cardiovascular and stroke endpoint definitions for clinical trials.","volume":"71","author":"Hicks","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"joi210128r28","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1001\/jama.2017.13276","article-title":"Gatekeeping strategies for avoiding false-positive results in clinical trials with many comparisons.","volume":"318","author":"Yadav","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"joi210128r29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046042","article-title":"Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice.","volume":"7","author":"Stewart","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"joi210128r30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/insr.v85.2","article-title":"A tutorial on multilevel survival analysis: methods, models and applications.","volume":"85","author":"Austin","year":"2017","journal-title":"Int Stat Rev"},{"issue":"4","key":"joi210128r31","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease.","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"joi210128r32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2307\/3001616","article-title":"Some methods for strengthening the common ?2 tests.","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"issue":"1","key":"joi210128r33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2307\/2983471","article-title":"Multiplicity considerations in the design and analysis of clinical trials.","volume":"159","author":"Cook","year":"1996","journal-title":"J Royal Stat Soc"},{"issue":"2","key":"joi210128r34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/10543406.2014.1000549","article-title":"Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.","volume":"26","author":"Zhao","year":"2016","journal-title":"J Biopharm Stat"},{"issue":"24","key":"joi210128r35","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1002\/sim.6197","article-title":"Sensitivity analysis for a partially missing binary outcome in a two-arm randomized clinical trial.","volume":"33","author":"Liublinska","year":"2014","journal-title":"Stat Med"},{"issue":"3","key":"joi210128r36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/pst.1738","article-title":"Sensitivity to censored-at-random assumption in the analysis of time-to-event endpoints.","volume":"15","author":"Lipkovich","year":"2016","journal-title":"Pharm Stat"},{"issue":"4","key":"joi210128r37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.v30.4","article-title":"Multiple imputation using chained equations: issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"1","key":"joi210128r38","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-3668","article-title":"The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement: explanation and elaboration.","volume":"172","author":"Kent","year":"2020","journal-title":"Ann Intern Med"},{"issue":"8","key":"joi210128r39","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials.","volume":"67","author":"Kent","year":"2016","journal-title":"J Am Coll Cardiol"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2787115\/jama_kent_2021_oi_210128_1643136284.31655.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T14:00:24Z","timestamp":1643119224000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2787115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":39,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021,12,14]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.20956","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741322105.793590744","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,14]]}}}